Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023

  • ID: 4457285
  • Report
  • Region: Global
  • 225 Pages
  • Markets and Markets
1 of 5
The Esoteric Testing Market is Projected to Reach USD 35.24 Billion By 2023 from USD 20.38 Billion in 2018, at a CAGR of 11.6%.

FEATURED COMPANIES

  • ACM Global Laboratories
  • Foundation Medicine
  • Healthscope
  • Labcorp
  • Miraca Holdings
  • Opko Health
  • MORE

“Esoteric testing market projected to grow at a CAGR of 11.6%”

Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, and increasing government funding for the research and development of innovative esoteric tests. Moreover, the introduction of a new range of condition-specific markers and tests, with advances in genomics and proteomics, is expected to offer significant growth opportunities for market players during the forecast period. However, the dearth of skilled laboratory technicians and inadequate reimbursement will limit the growth of this market.

“The infectious diseases testing segment is expected to dominate the market during the forecast period”

In 2018, on the basis of type, the infectious diseases testing segment is expected to account for the largest share of the market during the forecast period.The large share of this segment is primarily attributed to the rising incidence/prevalence of target diseases (chronic, infectious, & lifestyle related diseases), the increasing adoption of advanced technologies, and the growing healthcare expenditure across the globe.

“The independent & reference laboratories segment is projected to be the fastest growing during the forecast period”

In 2018, on the basis of laboratory type, the independent & reference laboratories segment is expected to register the highest growth rate during the forecast period, owing to a large number of patient diagnosis undertaken for target diseases worldwide and competitive benefits offered by these providers over hospital-based laboratories.

“Asia Pacific is expected to register the highest growth rate during the forecast period”

Geographically, the esoteric testing market is segmented into North America, Europe, Asia Pacific, Rest of Latin America, and Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to rising penetration of cutting-edge clinical laboratory technologies among masses (especially in rural areas) in Asia Pacific countries, development in healthcare infrastructure, and significant rise in the disposable income in the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type - Tier 1 - 48%, Tier 2 - 40% and Tier 3 - 12%
  • By Designation - C-level - 26%, Director-level - 30%, Others - 44%
  • By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%

List of companies profiled in the report

  • Labcorp (US)
  • Quest Diagnostics (US)
  • OPKO Health (US)
  • Miraca holdings (Japan)
  • Myriad Genetics (US)
  • Sonic Healthcare (Australia)
  • Primary Healthcare (Australia)
  • Healthscope (Australia)
  • Foundation Medicine (US)
  • ACM Global Laboratories (US)
  • Arup Laboratories (US)
  • Fulgent Genetics (US)
  • InVitae (US)
  • Mayo Medical Laboratories (US)
  • Spectra Laboratories (US)

Research Coverage

This report studies the esoteric testing market based on type, technology, laboratory type, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall esoteric testing market and its segments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ACM Global Laboratories
  • Foundation Medicine
  • Healthscope
  • Labcorp
  • Miraca Holdings
  • Opko Health
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Regional Scope
1.4 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Triangulation
2.4 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Attractive Market Opportunities in the Esoteric Testing Market
4.2 Asia Pacific: Market, By Type
4.3 Global Market: Regional Growth Opportunities
4.4 Global Market: Regional Mix
4.5 Global Market: Developed vs Developing Countries

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population and Subsequent Growth in the Prevalence of Chronic Diseases
5.2.1.2 Increasing Burden of Infectious Diseases
5.2.1.3 Rising Demand for Early Disease Detection Using Specialized Diagnostic Tests
5.2.1.4 Growing Awareness of Personalized Medicine
5.2.1.5 Increasing Funding and Research Grants for the Development of Innovative Esoteric Tests
5.2.2 Restraints
5.2.2.1 Unfavorable Reimbursement Scenario
5.2.3 Opportunities
5.2.3.1 Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
5.2.3.2 Growth Opportunities in Emerging Countries
5.2.4 Challenges
5.2.4.1 Changing Regulatory Landscape

6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 US
6.3.1.2 Canada
6.3.2 Europe
6.3.3 Asia-Pacific
6.3.3.1 Japan
6.3.3.2 India
6.3.3.3 China

7 Esoteric Testing Market, By Type
7.1 Introduction
7.2 Infectious Diseases Testing
7.3 Endocrinology Testing
7.4 Oncology Testing
7.5 Genetic Testing
7.6 Toxicology Testing
7.7 Immunology Testing
7.8 Neurology Testing
7.9 Others

8 Esoteric Testing Market, By Technology
8.1 Introduction
8.2 Chemiluminescence Immunoassay
8.3 Enzyme-Linked Immunosorbent Assay
8.4 Mass Spectrometry
8.5 Real-Time PCR
8.6 Flow Cytometry
8.7 Radioimmunoassay
8.8 Other Technologies

9 Global Esoteric Testing Market, By Laboratory Type
9.1 Introduction
9.2 Independent & Reference Laboratories
9.3 Hospital Laboratories

10 Esoteric Testing Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2016
11.3 Competitive Scenario
11.3.1 Product Launches
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Mergers and Acquisitions
11.3.4 Expansions

12 Company Profiles
(Business Overview, Products Offered, Recent Developments, SWOT Anlysis, MnM View.)*
12.1 Labcorp
12.2 Quest Diagnostics
12.3 Opko Health
12.4 Miraca Holdings
12.5 Myriad Genetics
12.6 Sonic Healthcare
12.7 Primary Health Care
12.8 Healthscope
12.9 Foundation Medicine
12.10 ACM Global Laboratories
12.11 Arup Laboratories
12.12 Fulgent Genetics
12.13 Invitae
12.14 Mayo Medical Laboratories
12.15 Spectra Laboratories
*Business Overview, Products Offered, Recent Developments, SWOT Anlysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables
Table 1 New Tests Launches By Key Players
Table 2 Esoteric Testing Market: Recent Acquisitions
Table 3 Global Market: Recent Collaborations and Agreements
Table 4 Stringency of Regulations for Clinical Laboratory Accreditation, By Country
Table 5 Accreditation Bodies in Europe
Table 6 Global Market, By Type, 2016-2023 (USD Million)
Table 7 Esoteric Tests for Infectious Diseases, By Key Market Player
Table 8 Infectious Diseases Esoteric Testing Market, By Country/Region, 2016-2023 (USD Million)
Table 9 Esoteric Tests for Endocrine Diseases, By Key Market Player
Table 10 Endocrinology Esoteric Testing Market, By Country/Region, 2016-2023 (USD Million)
Table 11 Esoteric Tests for Oncological Diseases, By Key Market Player
Table 12 Oncology Esoteric Testing Market, By Country/Region, 2016-2023 (USD Million)
Table 13 Esoteric Tests for Genetic Disorders, By Key Market Player
Table 14 Genetics Esoteric Testing Market, By Country/Region, 2016-2023 (USD Million)
Table 15 Esoteric Tests for Toxicology, By Key Market Player
Table 16 Toxicology Esoteric Testing Market, By Country/Region, 2016-2023 (USD Million)
Table 17 Esoteric Tests for Immunological Diseases, By Key Market Player
Table 18 Immunology Esoteric Testing Market, By Country/Region, 2016-2023 (USD Million)
Table 19 Esoteric Tests for Neurological Disorders, By Key Market Player
Table 20 Neurology Esoteric Testing Market, By Country/Region, 2016-2023 (USD Million)
Table 21 Other Esoteric Testing Market, By Country/Region, 2016-2023 (USD Million)
Table 22 Global Market, By Technology, 2016-2023 (USD Million)
Table 23 Chemiluminescence Immunoassay Market for Esoteric Testing, By Country/Region, 2016-2023 (USD Million)
Table 24 Enzyme-Linked Immunosorbent Assay Market for Esoteric Testing, By Country/Region, 2016-2023 (USD Million)
Table 25 Mass Spectrometry Market for Esoteric Testing, By Country/Region, 2016-2023 (USD Million)
Table 26 Real-Time PCR Market for Esoteric Testing, By Country/Region, 2016-2023 (USD Million)
Table 27 Flow Cytometry Market for Esoteric Testing, By Country/Region, 2016-2023 (USD Million)
Table 28 Radioimmunoassay Market for Esoteric Testing, By Country/Region, 2016-2023 (USD Million)
Table 29 Other Esoteric Technologies Market, By Country/Region, 2016-2023 (USD Million)
Table 30 Global Market, By Laboratory Type, 2016-2023 (USD Million)
Table 31 Global Market for Independent & Reference Laboratories, By Country/Region, 2016-2023 (USD Million)
Table 32 Global Market for Hospital Laboratories, By Country/Region, 2016-2023 (USD Million)
Table 33 Global Market, By Region, 2016-2023 (USD Million)
Table 34 North America: Esoteric Testing Market, By Country, 2016-2023 (USD Million)
Table 35 North America: Market, By Type, 2016-2023 (USD Million)
Table 36 North America: Market, By Technology, 2016-2023 (USD Million)
Table 37 North America: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 38 U.S.: Infectious Disease Incidence, 2008-2012
Table 39 US: Key Macroindicators
Table 40 US: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 41 US: Market, By Technology, 2016-2023 (USD Million)
Table 42 US: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 43 Canada: Key Macroindicators
Table 44 Canada: Market, By Type, 2016-2023 (USD Million)
Table 45 Canada: Esoteric Testing Market, By Technology, 2016-2023 (USD Million)
Table 46 Canada: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 47 Europe: Market, By Country/Region, 2016-2023 (USD Million)
Table 48 Europe: Market, By Type, 2016-2023 (USD Million)
Table 49 Europe: Esoteric Testing Market, By Technology, 2016-2023 (USD Million)
Table 50 Europe: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 51 Germany: Key Macroindicators
Table 52 Germany: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 53 Germany: Market, By Technology, 2016-2023 (USD Million)
Table 54 Germany: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 55 France: Key Macroindicators
Table 56 France: Market, By Type, 2016-2023 (USD Million)
Table 57 France Esoteric Testing Market, By Technology, 2016-2023 (USD Million)
Table 58 France: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 59 UK: Key Macroindicators
Table 60 UK: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 61 UK: Market, By Technology, 2016-2023 (USD Million)
Table 62 UK: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 63 Italy: Key Macroindicators
Table 64 Italy: Market, By Type, 2016-2023 (USD Million)
Table 65 Italy: Esoteric Testing Market, By Technology, 2016-2023 (USD Million)
Table 66 Italy: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 67 Spain: Key Macroindicators
Table 68 Spain: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 69 Spain: Market, By Technology, 2016-2023 (USD Million)
Table 70 Spain: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 71 RoE: Market, By Type, 2016-2023 (USD Million)
Table 72 RoE: Esoteric Testing Market, By Technology, 2016-2023 (USD Million)
Table 73 RoE: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 74 Asia Pacific: Market, By Country/Region, 2016-2023 (USD Million)
Table 75 Asia Pacific: Market, By Type, 2016-2023 (USD Million)
Table 76 Asia Pacific: Esoteric Testing Market, By Technology, 2016-2023 (USD Million)
Table 77 Asia Pacific: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 78 Japan: Key Macroindicators
Table 79 Japan: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 80 Japan: Market, By Technology, 2016-2023 (USD Million)
Table 81 Japan: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 82 China: Key Macroindicators
Table 83 China: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 84 China: Market, By Technology, 2016-2023 (USD Million)
Table 85 China: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 86 India: Key Macroindicators
Table 87 India: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 88 India: Market, By Technology, 2016-2023 (USD Million)
Table 89 India: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 90 RoAPAC: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 91 RoAPAC: Market, By Technology, 2016-2023 (USD Million)
Table 92 RoAPAC: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 93 Rest of Latin America: Market, By Country/Region, 2016-2023 (USD Million)
Table 94 Latin America: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 95 Latin America: Market, By Technology, 2016-2023 (USD Million)
Table 96 Latin America: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 97 Brazil: Key Macroindicators
Table 98 Brazil: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 99 Brazil: Market, By Technology, 2016-2023 (USD Million)
Table 100 Brazil: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 101 Mexico: Key Macroindicators
Table 102 Mexico: Esoteric Testing Market, By Type, 2016-2023 (USD Million)
Table 103 Mexico: Market, By Technology, 2016-2023 (USD Million)
Table 104 Mexico: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 105 Rest of Latin America: Market, By Type, 2016-2023 (USD Million)
Table 106 Rest of Latin America: Esoteric Testing Market, By Technology, 2016-2023 (USD Million)
Table 107 Rest of Latin America: Market, By Laboratory Type, 2016-2023 (USD Million)
Table 108 Middle East & Africa: Market, By Type, 2016-2023 (USD Million)
Table 109 Middle East & Africa: Market, By Technology, 2016-2023 (USD Million)
Table 110 Middle East & Africa: Esoteric Testing Market, By Laboratory Type, 2016-2023 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Data Triangulation Methodology
Figure 3 Infectious Disease Testing Segment to Dominate the Global Esoteric Testing Market, By Type, in 2018
Figure 4 Real-Time PCR Segment to Register the Highest Growth Rate in the global Market During the Forecast Period
Figure 5 Independent & Reference Laboratories to Be the Fastest-Growing Segment in the Market Between 2018 & 2023
Figure 6 Asia Pacific to Witness the Highest Growth Rate in the Forecast Period
Figure 7 Increasing Prevalence of Chronic & Infectious Diseases-Key Factor Driving the Growth of the Market
Figure 8 Genetic Testing Segment to Register the Highest Growth Rate in the APAC Esoteric Testing Market During the Forecast Period
Figure 9 Emerging Countries to Register Highest CAGR During the Forecast Period
Figure 10 North America to Dominate the Esoteric Testing Market in the Forecast Period
Figure 11 Developing Countries to Register A Higher Growth Rate in the Forecast Period
Figure 12 Esoteric Testing Market: Drivers, Restraints, Opportunities, & Challenges
Figure 13 Increase in Geriatric Population, By Country 2011 vs 2015 vs 2030
Figure 14 Major Trend: Acquisitions Resulting in Market Consolidation
Figure 15 Esoteric Testing Market, By Type, 2018 vs 2023
Figure 16 Chemiluminescence Immunoassay Segment to Dominate the Esoteric Testing Market During the Forecast Period
Figure 17 Esoteric Testing Market, By Laboratory Type, 2018 vs 2023
Figure 18 Healthcare Expenditure Across Major Countries, 2000-2014
Figure 19 North America to Dominate the Market in 2023
Figure 20 Geographic Snapshot of the Global Market
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia Pacific: Market Snapshot
Figure 24 Players Majorly Adopted the Strategy of Product Launches Between January 2014 and March 2017
Figure 25 Global Esoteric Testing Market Share Analysis, By Key Player, 2016
Figure 26 Labcorp: Company Snapshot
Figure 27 Quest Diagnostics: Company Snapshot
Figure 28 Opko Health: Company Snapshot
Figure 29 Miraca Holdings: Company Snapshot
Figure 30 Myriad Genetics: Company Snapshot
Figure 31 Sonic Healthcare: Company Snapshot
Figure 32 Primary Health Care: Company Snapshot
Figure 33 Healthscope: Company Snapshot
Figure 34 Foundation Medicine: Company Snapshot
Figure 35 Fulgent Genetics: Company Snapshot
Figure 36 Mayo Medical Laboratories: Company Snapshot
Figure 37 Fresenius Medical Care: Company Snapshot

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • ACM Global Laboratories
  • Arup Laboratories
  • Foundation Medicine
  • Fulgent Genetics
  • Healthscope
  • Invitae
  • Labcorp
  • Mayo Medical Laboratories
  • Miraca Holdings
  • Myriad Genetics
  • Opko Health
  • Primary Health Care
  • Quest Diagnostics
  • Sonic Healthcare
  • Spectra Laboratories
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll